TAS2R14 and viral infectious disease: These results reveal TAS2Rs on human PBMCs being functionally active in the chemokine immune response to SARS-CoV-2-specific peptides, with the broadly tuned TAS2R14 as a promising target for anti-inflammatory immune system regulation in viral infections.